Susquehanna International Group, LLP Seagen Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $28.5 Million - $32.1 Million	-148,700 Reduced 19.53%	612,700 $130 Million
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $77.7 Million - $85.4 Million	414,000 Added 119.17%	761,400 $147 Million
Q1 2023 May 16, 2023	BUY	$127.59 - $203.08 $31.8 Million - $50.7 Million	249,500 Added 254.85%	347,400 $70.3 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $36.7 Million - $43.6 Million	-313,100 Reduced 76.18%	97,900 $12.6 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $39.7 Million - $52.9 Million	293,800 Added 250.68%	411,000 $56.2 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.